Drug · DIN 02299372
RAMIPRIL
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since March 10, 2021; first marketed March 17, 2008.
- Drug Identification Number (DIN)
- 02299372
- Company (DIN owner)
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Ramipril C09AA05
- Class
- Human
- Record last updated
- September 4, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RAMIPRIL | 1.25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 3, 2017: NOC 20004Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- March 14, 2008: NOC 9427Supplement to an Abbreviated New Drug Submission (SANDS) · Additional strength
Other DINs named RAMIPRIL
- DIN 02255316 · Marketed
- DIN 02255324 · Marketed
- DIN 02255332 · Marketed
- DIN 02287927 · Marketed
- DIN 02287935 · Marketed
- DIN 02287943 · Marketed
- DIN 02308363 · Marketed
- DIN 02342685 · Cancelled Pre Market
- DIN 02342693 · Cancelled Pre Market
- DIN 02342707 · Cancelled Pre Market
- DIN 02342715 · Cancelled Pre Market
- DIN 02374846 · Cancelled Post Market
- DIN 02374854 · Cancelled Post Market
- DIN 02374862 · Cancelled Post Market
- DIN 02469553 · Approved
- DIN 02486504 · Cancelled Pre Market
- DIN 02486512 · Cancelled Post Market
- DIN 02486520 · Cancelled Post Market
- DIN 02486539 · Cancelled Post Market
- DIN 02486547 · Cancelled Pre Market